We studied the correlation of the prediction model consisting of ROS1 gene mutations, KRAS gene mutations, tumor stage, and endocrine system disease history with PD-L1 expression, and we assessed whether the prediction model was an independent risk factor for survival prediction by the multivariable Cox regression analysis. Here, KRAS is linked to neoplasm.